Skip to content
LumenField

Zimbabwe Turns Down ‘Unbalanced’ American Health Aid Agreement Over Data Concerns

Health aid image
The offered US funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a significant US healthcare agreement worth $367m (272 million pounds) spanning five years due to Washington's request for sensitive data.

The decision came to light after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

A government spokesman has since explained that the US was demanding access to health data for scientific study and commercial purposes while refused to guarantee the benefits from future vaccines.

"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for more talks to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Implications

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court blocked a related health funding agreement after concerns were filed about the safety of Kenyans' medical information.

After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance openness and accountability.

According to reports, 16 nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Deal

This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our country would supply the basic resources for medical research without any assurance that the end products would be available to our citizens if a future health crisis arise."

Sovereignty and Global Health

He also said that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting frameworks previously set up through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.

"This mechanism is designed to guarantee that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to further dialogue with our American counterparts on how future collaboration might be structured in a manner that honours the sovereignty and dignity of both nations."

Health Experts Reaction

A leading public health body expressed it acknowledged the official position, but urged that talks should continue given that a large portion of the country's HIV programmes depended on foreign aid.

"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it commented.

This impasse underscores the complex challenges between receiving much-needed international aid and protecting local interests in an increasingly data-driven world.

About the author

Jamie Barnett MD

A technology strategist with over a decade of experience in AI and digital transformation, passionate about sharing knowledge.

LumenField

Type to search articles.